1
|
Buchanan C, Stigliano I, Garay-Malpartida HM, Rodrigues Gomes L, Puricelli L, Sogayar MC, Joffe EBDK, Peters MG. Retraction Note: Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways. Breast Cancer Res Treat 2023; 202:213. [PMID: 37667070 DOI: 10.1007/s10549-023-07120-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/06/2023]
Affiliation(s)
- C Buchanan
- Cell Biology Department, Research Area, Institute of Oncology "Angel H. Roffo", University of Buenos Aires, Av. San Martín 5481, C1417DTB, Buenos Aires, Argentina
| | - I Stigliano
- Cell Biology Department, Research Area, Institute of Oncology "Angel H. Roffo", University of Buenos Aires, Av. San Martín 5481, C1417DTB, Buenos Aires, Argentina
| | - H M Garay-Malpartida
- School of Arts, Sciences and Humanities, University of São Paulo, São Paulo, 05508-900, SP, Brazil
| | - L Rodrigues Gomes
- Chemistry Institute, University of São Paulo, São Paulo, 05508-900, SP, Brazil
| | - L Puricelli
- Cell Biology Department, Research Area, Institute of Oncology "Angel H. Roffo", University of Buenos Aires, Av. San Martín 5481, C1417DTB, Buenos Aires, Argentina
| | - M C Sogayar
- Chemistry Institute, University of São Paulo, São Paulo, 05508-900, SP, Brazil
| | - E Bal de Kier Joffe
- Cell Biology Department, Research Area, Institute of Oncology "Angel H. Roffo", University of Buenos Aires, Av. San Martín 5481, C1417DTB, Buenos Aires, Argentina
| | - M G Peters
- Cell Biology Department, Research Area, Institute of Oncology "Angel H. Roffo", University of Buenos Aires, Av. San Martín 5481, C1417DTB, Buenos Aires, Argentina.
| |
Collapse
|
3
|
Arthur RA, Dos Santos Bezerra R, Ximenez JPB, Merlin BL, de Andrade Morraye R, Neto JV, Fava NMN, Figueiredo DLA, de Biagi CAO, Montibeller MJ, Guimarães JB, Alves EG, Schreiner M, da Costa TS, da Silva CFL, Malheiros JM, da Silva LHB, Ribas GT, Achallma DO, Braga CM, Andrade KFA, do Carmo Alves Martins V, Dos Santos GVN, Granatto CF, Terin UC, Sanches IH, Ramos DE, Garay-Malpartida HM, de Souza GMP, Slavov SN, Silva WA. Microbiome and oral squamous cell carcinoma: a possible interplay on iron metabolism and its impact on tumor microenvironment. Braz J Microbiol 2021; 52:1287-1302. [PMID: 34002353 PMCID: PMC8324744 DOI: 10.1007/s42770-021-00491-6] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2020] [Accepted: 04/06/2021] [Indexed: 12/23/2022] Open
Abstract
There is increasing evidence showing positive association between changes in oral microbiome and the occurrence of oral squamous cell carcinoma (OSCC). Alcohol- and nicotine-related products can induce microbial changes but are still unknown if these changes are related to cancerous lesion sites. In an attempt to understand how these changes can influence the OSCC development and maintenance, the aim of this study was to investigate the oral microbiome linked with OSCC as well as to identify functional signatures and associate them with healthy or precancerous and cancerous sites. Our group used data of oral microbiomes available in public repositories. The analysis included data of oral microbiomes from electronic cigarette users, alcohol consumers, and precancerous and OSCC samples. An R-based pipeline was used for taxonomic and functional prediction analysis. The Streptococcus spp. genus was the main class identified in the healthy group. Haemophilus spp. predominated in precancerous lesions. OSCC samples revealed a higher relative abundance compared with the other groups, represented by an increased proportion of Fusobacterium spp., Prevotella spp., Haemophilus spp., and Campylobacter spp. Venn diagram analysis showed 52 genera exclusive of OSCC samples. Both precancerous and OSCC samples seemed to present a specific associated functional pattern. They were menaquinone-dependent protoporphyrinogen oxidase pattern enhanced in the former and both 3',5'-cyclic-nucleotide phosphodiesterase (purine metabolism) and iron(III) transport system ATP-binding protein enhanced in the latter. We conclude that although precancerous and OSCC samples present some differences on microbial profile, both microbiomes act as "iron chelators-like" potentially contributing to tumor growth.
Collapse
Affiliation(s)
- Rodrigo Alex Arthur
- Preventive and Community Dentistry Department, Faculty of Dentistry, Federal University of Rio Grande do Sul, Porto Alegre, RS, 90035-003, Brazil
| | - Rafael Dos Santos Bezerra
- Postgraduate Program in Clinical Oncology, Stem Cells and Cell Therapy, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, 14049-900, Brazil
- Center for Cell-Based Therapy (CEPID/FAPESP), Molecular Genetics and Bioinformatics Laboratory - MGBL, National Institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Rua Tenente Catão Roxo, 2501, Ribeirão Preto, SP, 14049-900, Brazil
| | - João Paulo Bianchi Ximenez
- Center for Cell-Based Therapy (CEPID/FAPESP), Molecular Genetics and Bioinformatics Laboratory - MGBL, National Institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Rua Tenente Catão Roxo, 2501, Ribeirão Preto, SP, 14049-900, Brazil
- Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, 14049-900, Brazil
| | - Bruna Laís Merlin
- Department of Entomology and Acarology, Luiz de Queiroz College of Agriculture, University of São Paulo, Piracicaba, SP, 13418-900, Brazil
| | - Raphael de Andrade Morraye
- Center for Cell-Based Therapy (CEPID/FAPESP), Molecular Genetics and Bioinformatics Laboratory - MGBL, National Institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Rua Tenente Catão Roxo, 2501, Ribeirão Preto, SP, 14049-900, Brazil
- Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, 14049-900, Brazil
- Ribeirão Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, 14049-900, Brazil
| | - João Valentini Neto
- Department of Nutrition, School of Public Health, University of Sao Paulo, São Paulo, SP, 01246-904, Brazil
| | - Natália Melo Nasser Fava
- Department of Hydraulics and Sanitation, São Carlos School of Engineering, University of São Paulo, São Carlos, SP, 13563-120, Brazil
| | - David Livingstone Alves Figueiredo
- Institute for Cancer Research (IPEC), Guarapuava, PR, 85015-430, Brazil
- Department of Medicine, UNICENTRO, Guarapuava, PR, 85015-430, Brazil
| | - Carlos Alberto Oliveira de Biagi
- Center for Cell-Based Therapy (CEPID/FAPESP), Molecular Genetics and Bioinformatics Laboratory - MGBL, National Institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Rua Tenente Catão Roxo, 2501, Ribeirão Preto, SP, 14049-900, Brazil
- Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, 14049-900, Brazil
| | - Maria Jara Montibeller
- Department of Food and Nutrition, School of Pharmaceutical Sciences, São Paulo State University, Araraquara, SP, Brazil
| | - Jhefferson Barbosa Guimarães
- Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirão Preto, SP, Brazil
| | - Ellen Gomes Alves
- Undergraduate in Biological Sciences, Institute of Health Sciences, Universidade Paulista, Ribeirão Preto, SP, Brazil
| | - Monique Schreiner
- Graduate Program in Bioinformatics, Professional and Technological Education Sector, Federal University of Paraná, Curitiba, PR, Brazil
| | - Tiago Silva da Costa
- Department of Biological Sciences and Health, Federal University of Amapá, Macapá, AP, Brazil
| | - Charlie Felipe Liberati da Silva
- Graduate Program in Bioinformatics, Professional and Technological Education Sector, Federal University of Paraná, Curitiba, PR, Brazil
| | | | - Luan Henrique Burda da Silva
- Graduate Program in Bioinformatics, Professional and Technological Education Sector, Federal University of Paraná, Curitiba, PR, Brazil
| | - Guilherme Taborda Ribas
- Graduate Program in Bioinformatics, Professional and Technological Education Sector, Federal University of Paraná, Curitiba, PR, Brazil
| | - Daisy Obispo Achallma
- Laboratorios de Investigación y Desarrollo, FARVET, Chincha Alta, Ica, Perú & Centro de Investigación de Genética y Biología Molecular (CIGBM), Universidad de San Martín de Porres, Lima, Perú
| | - Camila Margalho Braga
- Graduate Program in Parasitic Biology in the Amazon, Pará State University, Belém, PA, Brazil
| | - Karen Flaviane Assis Andrade
- Department of Electrical and Biomedical Engineering, Institute of Technology, Federal University of Pará, Belém, PA, Brazil
| | | | | | | | | | - Igor Henrique Sanches
- Institute of Pathology Tropical and Public Health, Federal University of Goiás, Goiânia, GO, Brazil
| | - Diana Estefania Ramos
- Department of Oral; Maxillofacial Surgery, and Periodontology, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil
| | | | - Gabriela Marcelino Pereira de Souza
- Center for Cell-Based Therapy (CEPID/FAPESP), Molecular Genetics and Bioinformatics Laboratory - MGBL, National Institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Rua Tenente Catão Roxo, 2501, Ribeirão Preto, SP, 14049-900, Brazil
| | - Svetoslav Nanev Slavov
- Center for Cell-Based Therapy (CEPID/FAPESP), Molecular Genetics and Bioinformatics Laboratory - MGBL, National Institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Rua Tenente Catão Roxo, 2501, Ribeirão Preto, SP, 14049-900, Brazil
| | - Wilson Araújo Silva
- Center for Cell-Based Therapy (CEPID/FAPESP), Molecular Genetics and Bioinformatics Laboratory - MGBL, National Institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Rua Tenente Catão Roxo, 2501, Ribeirão Preto, SP, 14049-900, Brazil.
- Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, 14049-900, Brazil.
- Center for Cell-Based Therapy (CEPID/FAPESP), Molecular Genetics and Bioinformatics Laboratory - MGBL, Blood Center of Ribeirão Preto, Rua Tenente Catão Roxo, 2501 - 14051-140 Ribeirão Preto, São Paulo, Brasil.
| |
Collapse
|
4
|
Caldeira I, Maciel-Silva P, Siqueira FR, Goldberg AC, Nunes VA, Belizario JE, Garay-Malpartida HM. Abstract 2331: FAM3B/PANDER inhibits cell death and increases tumor growth by modulating the expression of Bcl-2 and Bcl-XL cell survival genes. Cancer Res 2017. [DOI: 10.1158/1538-7445.am2017-2331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
FAM3B/PANDER is a novel cytokine-like protein that induces apoptosis in insulin-secreting beta-cells. Since in silico data revealed that FAM3B can be expressed by prostate and breast tumors, we evaluated the putative role of this cytokine in prostate and breast tumor progression. The FAM3B expression was compared by quantitative PCR in LnCAP, PC-3 and DU145 prostate tumor cell lines and MCF-7, ZR-75 and MDA-MB-231 breast tumor cell lines. After treatment with either recombinant FAM3B protein or secreted FAM3B obtained from conditioned media (CM) derived from FAM3B-overexpressing 293T cells , the cell death and viability of DU145 and MDA-MB-231 cell lines were evaluated. DU145 and MDA-MB-231 cells overexpressing FAM3B protein were produced by lentiviral-mediated transduction of full-length FAM3B cDNA. Cell viability and apoptosis were analyzed in DU145-FAM3B and MDA-231-FAM3B cells after treatment with several cell death inducers. Anchorage-independent growth and scratch wound assays were used to evaluate in vitro tumorigenicity and cell migration, respectively. In vivo tumorigenicity and invasiveness were evaluated by tumor xenograft growth in nude mice. We observed that FAM3B was highly expressed by hormone responsive cells (LnCAP and MCF-7) and low expressed in unresponsive hormone cells (PC-3, DU145 and MDA-MB-231). Cell viability and survival of DU145 and MDA-MB-231 cells increased after exogenous treatment with recombinant FAM3B protein or CM containing FAM3B-secreted protein. Overexpression of FAM3B in DU145 and MDA-MB-231 cells promoted an inhibition of apoptosis triggered by TNF-alpha, staurosporine and serum-deprived conditions. Cell death inhibition was accompanied by increased gene expression of the anti-apoptotic Bcl-2 and Bcl-xL genes, and by slight decrease in expression of pro-apoptotic gene Bax and diminished caspases-3, -8 and -9 proteolytic activities. When compared to control, cells overexpressing FAM3B displayed a decreased anchorage independent growth and increased motility in vitro, as well as an increased tumor growth in xenografted nude mice. The immunohistochemistry analysis from tumor xenografts revealed similar anti-apoptotic phenotype displayed by FAM3B-overexpressing tumor cells. Taken together, by activating pro-survival mechanisms, FAM3B overexpression contribute to increased cell death resistance and tumor growth in nude mice, highlighting a putative role for this cytokine in prostate and breast cancer progression.
Note: This abstract was not presented at the meeting.
Citation Format: Izabela Caldeira, Paula Maciel-Silva, Flavia Ramos Siqueira, Anna Carla Goldberg, Viviane Abreu Nunes, Jose Ernesto Belizario, Humberto Miguel Garay-Malpartida. FAM3B/PANDER inhibits cell death and increases tumor growth by modulating the expression of Bcl-2 and Bcl-XL cell survival genes [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 2331. doi:10.1158/1538-7445.AM2017-2331
Collapse
|
5
|
Café-Mendes CC, Garay-Malpartida HM, Malta MB, de Sá Lima L, Scavone C, Ferreira ZS, Markus RP, Marcourakis T. Chronic nicotine treatment decreases LPS signaling through NF-κB and TLR-4 modulation in the hippocampus. Neurosci Lett 2016; 636:218-224. [PMID: 27984197 DOI: 10.1016/j.neulet.2016.10.056] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2016] [Revised: 10/09/2016] [Accepted: 10/20/2016] [Indexed: 01/30/2023]
Abstract
The hippocampus is a brain region that is rich in nicotinic acetylcholine receptors (nAChRs), especially the α7 subtype. The hippocampus is severely affected in disorders that have a neuroinflammatory component, such as Alzheimer's disease, Parkinson's disease, and schizophrenia. Previous studies demonstrated both in vivo and in vitro that nicotine inhibits immunological responses, including those that are triggered by the inflammatory agent lipopolysaccharide (LPS), the endotoxin of Gram-negative bacteria. The present study investigated whether chronically administered nicotine interferes with the nuclear binding of nuclear factor-κB (NF-κB) and the expression of LPS-induced inflammatory response genes. The results indicated that chronic nicotine administration (0.1mg/kg, s.c., 14days) inhibited the LPS-induced nuclear binding of NF-κB and mRNA expression levels of Tnf, Il1b, Nos2, and Tlr4. The presence of both the selective α7 nAChR antagonist methyllycaconitine (MLA; 5.0mg/kg i.p., 14days) and the nonselective nAChR antagonist mecamylamine (Meca; 1.0mg/kg, s.c., 14days) reversed the inhibitory effects of nicotine. These results suggest that the chronic activation of α7- and αxβy-containing nAChRs reduces acute inflammatory responses in the brain.
Collapse
Affiliation(s)
- Cecília Cerqueira Café-Mendes
- Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; School of Medicine, University of São Paulo, São Paulo, Brazil
| | | | - Marília Brinati Malta
- Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
| | - Larrissa de Sá Lima
- Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
| | - Cristóforo Scavone
- Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
| | - Zulma S Ferreira
- Laboratory of Chronopharmacology, Department of Physiology, Institute of Biosciences, University of São Paulo, São Paulo, Brazil
| | - Regina P Markus
- Laboratory of Chronopharmacology, Department of Physiology, Institute of Biosciences, University of São Paulo, São Paulo, Brazil
| | - Tania Marcourakis
- Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
| |
Collapse
|